Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 1
2010 1
2011 2
2012 1
2013 1
2021 2
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
The OncoSim-Breast Cancer Microsimulation Model.
Yong JHE, Nadeau C, Flanagan WM, Coldman AJ, Asakawa K, Garner R, Fitzgerald N, Yaffe MJ, Miller AB. Yong JHE, et al. Among authors: asakawa k. Curr Oncol. 2022 Mar 3;29(3):1619-1633. doi: 10.3390/curroncol29030136. Curr Oncol. 2022. PMID: 35323336 Free PMC article.
Estimates of future cancer mortality attributable to modifiable risk factors in Canada.
Pader J, Ruan Y, Poirier AE, Asakawa K, Lu C, Memon S, Miller A, Walter S, Villeneuve PJ, King WD, Volesky KD, Smith L, De P, Friedenreich CM, Brenner DR. Pader J, et al. Among authors: asakawa k. Can J Public Health. 2021 Dec;112(6):1069-1082. doi: 10.17269/s41997-020-00455-7. Epub 2021 May 25. Can J Public Health. 2021. PMID: 34036522 Free PMC article.
Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study.
Uemura H, Kobayashi K, Yokomizo A, Hinotsu S, Horie S, Kakehi Y, Nonomura N, Ogawa O, Oya M, Suzuki K, Saito A, Asakawa K, Uno S, Naito S. Uemura H, et al. Among authors: asakawa k. Int J Clin Oncol. 2022 Oct;27(10):1632-1643. doi: 10.1007/s10147-022-02221-w. Epub 2022 Aug 10. Int J Clin Oncol. 2022. PMID: 35948732 Free PMC article.
Estimating the future cancer management costs attributable to modifiable risk factors in Canada.
Ruan Y, Poirier AE, Pader J, Asakawa K, Lu C, Memon S, Miller AB, Walter SD, Villeneuve PJ, King WD, Volesky KD, Smith L, De P, Friedenreich CM, Brenner DR. Ruan Y, et al. Among authors: asakawa k. Can J Public Health. 2021 Dec;112(6):1083-1092. doi: 10.17269/s41997-021-00502-x. Epub 2021 May 25. Can J Public Health. 2021. PMID: 34036521 Free PMC article.
Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world administrative database study in Japan.
Kashiwagi A, Shoji S, Kosakai Y, Koga T, Asakawa K, Rokuda M. Kashiwagi A, et al. Among authors: asakawa k. J Diabetes Investig. 2023 Mar;14(3):404-416. doi: 10.1111/jdi.13952. Epub 2022 Dec 14. J Diabetes Investig. 2023. PMID: 36515129 Free PMC article.
Canadian Cancer Risk Management Model: evaluation of cancer control.
Evans WK, Wolfson MC, Flanagan WM, Shin J, Goffin J, Miller AB, Asakawa K, Earle C, Mittmann N, Fairclough L, Oderkirk J, Finès P, Gribble S, Hoch J, Hicks C, Omariba DW, Ng E. Evans WK, et al. Among authors: asakawa k. Int J Technol Assess Health Care. 2013 Apr;29(2):131-9. doi: 10.1017/S0266462313000044. Epub 2013 Mar 20. Int J Technol Assess Health Care. 2013. PMID: 23514623
15 results